Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
There are no standards requiring radiologists to report on the presence of BACs, even though up to half of referring providers have indicated they would prefer to be made aware of the finding.
Breast artery calcifications are already visible when radiologists review mammograms, but nothing typically happens with them. Researchers aimed to see if AI could help translate those findings into an easy-to-understand cardiovascular risk score.
Despite the great progress that has been made toward the clinical implementation of AI, new data caution against trusting the technology as a single reader in certain settings.
Women who skipped screening due to financial concerns outnumbered those who were not screened due to logistical issues such as scheduling and transportation conflicts, new survey data reveals.
Individuals at high risk of pancreatic cancer benefit from annual imaging and have decreased mortality rates compared to those who forgo preventive screening.
In the June 29 announcement, the ACR revealed CMS said the additional evidence provided to them was “insufficient” to support the reconsideration of their non-coverage decision.
In addition to CE-MRI's increased sensitivity for identifying breast cancers, the researchers also found the modality had superior negative likelihood ratios with higher pre-test probabilities for safely ruling out malignancy.
Assessing more than 11,000 patients with lesions designated as BI-RADS 4, radiologists using digital breast tomosynthesis found no significant diagnostic advantages over standard 2D mammography.